Plasma and urinary markers of oral testosterone undecanoate misuse

被引:45
作者
Peng, SH
Segura, J [1 ]
Farré, M
González, JC
de la Torre, X
机构
[1] Inst Municipal Invest Med, E-08003 Barcelona, Spain
[2] Univ Pompeu Fabra, Barcelona, Spain
[3] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
关键词
oral testosterone undecanoate; doping; plasma; urine; gas chromatography/mass spectrometry;
D O I
10.1016/S0039-128X(01)00128-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Orally administered testosterone undecanoate (TU), an anabolic, androgenic steroid, can potentially be abused by athletes. Indirect evidence for detecting oral TU intake could be deduced from the changes in steroid profile post-administration. Direct evidence could be obtained by detection of unchanged TU in plasma. To this end, both urinary and plasma steroid profiles of six healthy male subjects given a single oral dose of 120 mg of TU were studied by gas chromatography/mass spectrometry (GC/MS) and gas chromatography/tandem mass spectrometry (GC/MS/MS). The increased concentration of glucuronidated testosterone in plasma appears to be the most characteristic sign of oral TU intake. The testosterone glucuronide (TG)/nonconjugated testosterone (T) ratio, TG/17-hydroxyprogesterone (17OHP) ratio, and TG/luteinizing hormone (LH) ratio were observed to be significantly elevated above their basal levels for 10 h, 10 h, and 6 h, respectively. Urinary ratios of TG/epitestosterone glucuronide (EG) were found to be higher than the cut-off value of 6 for the period 4 similar to8 h post-administration, but only in three subjects. One subject failed to respond with respect to all of the above-mentioned indirect markers, as TG was not significantly increased in either plasma or urine. Unchanged TU was directly detected in plasma of all six subjects from 1 similar to1.5 h to 4 similar to6 h after oral TU intake by GC/MS/MS, providing unequivocal proof of exogenous testosterone intake. Distinct and complementary markers for detecting oral TU intake could be obtained from plasma and urine, respectively. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 34 条
[1]   Screening urine for exogenous testosterone by isotope ratio mass spectrometric analysis of one pregnanediol and two androstanediols [J].
Aguilera, R ;
Catlin, DH ;
Becchi, M ;
Phillips, A ;
Wang, C ;
Swerdloff, RS ;
Pope, HG ;
Hatton, CK .
JOURNAL OF CHROMATOGRAPHY B, 1999, 727 (1-2) :95-105
[2]   GAS-CHROMATOGRAPHY COMBUSTION ISOTOPE RATIO MASS-SPECTROMETRY ANALYSIS OF URINARY STEROIDS TO DETECT MISUSE OF TESTOSTERONE IN SPORT [J].
BECCHI, M ;
AGUILERA, R ;
FARIZON, Y ;
FLAMENT, MM ;
CASABIANCA, H ;
JAMES, P .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 1994, 8 (04) :304-308
[3]  
CARLSTROM K, 1992, CLIN CHEM, V38, P1779
[4]  
Catlin D H, 1991, Adv Intern Med, V36, P399
[5]   PHARMACOLOGY AND METABOLISM OF TESTOSTERONE UNDECANOATE (TU), A NEW ORALLY ACTIVE ANDROGEN [J].
COERT, A ;
GEELEN, J ;
VISSER, JD ;
VANDERVIES, J .
ACTA ENDOCRINOLOGICA, 1975, 79 (04) :789-800
[6]   INCREASING CIRCULATING ANDROGENS WITH ORAL TESTOSTERONE UNDECANOATE IN EUGONADAL MEN [J].
DAVIDSON, DW ;
OCARROLL, R ;
BANCROFT, J .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 26 (06) :713-715
[7]  
De la Torre X., 1995, RECENT ADV DOPING AN, V2, P59
[8]  
de la Torre X, 1997, RECENT ADV DOPING AN, V4, P71
[9]   Glucuronidation in humans - Pharmacogenetic and developmental aspects [J].
de Wildt, SN ;
Kearns, GL ;
Leeder, JS ;
van den Anker, JN .
CLINICAL PHARMACOKINETICS, 1999, 36 (06) :439-452